1-5 of 5
MJ Glennie
Close
Sort by
Journal Articles

HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor

D Elsasser, T Valerius, R Repp, GJ Weiner, Y Deo, JR Kalden, JG van de Winkel, GT Stevenson, MJ Glennie, M Gramatzki
Journal: Blood
Blood (1996) 87 (9): 3803–3812.
https://doi.org/10.1182/blood.V87.9.3803.bloodjournal8793803
Published: 1996
Journal Articles

Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma

RJ Dearman, FK Stevenson, M Wrightham, TJ Hamblin, MJ Glennie, GT Stevenson
Journal: Blood
Blood (1988) 72 (6): 1985–1991.
https://doi.org/10.1182/blood.V72.6.1985.1985
Published: 1988
Journal Articles

Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody

TJ Hamblin, AR Cattan, MJ Glennie, MR MacKenzie, FK Stevenson, HF Watts, GT Stevenson
Journal: Blood
Blood (1987) 69 (3): 790–797.
https://doi.org/10.1182/blood.V69.3.790.790
Published: 1987
Journal Articles

Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes

M Wrightham, AL Tutt, MJ Glennie, TJ Hamblin, GT Stevenson, FK Stevenson
Journal: Blood
Blood (1987) 69 (3): 919–923.
https://doi.org/10.1182/blood.V69.3.919.919
Published: 1987
Journal Articles

Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors

FK Stevenson, M Wrightham, MJ Glennie, DB Jones, AR Cattan, T Feizi, TJ Hamblin, GT Stevenson
Journal: Blood
Blood (1986) 68 (2): 430–436.
https://doi.org/10.1182/blood.V68.2.430.430
Published: 1986